Company
Koninklijke Philips N.V.
Headquarters: Amsterdam, Netherlands
Founded: 15 May 1891
Employees: 78,189
CEO: Mr. François Adrianus van Houten
Market Cap
€19.43 Billion
EUR as of Jan. 1, 2024
US$21.46 Billion
Koninklijke Philips N.V. Categories
Netherlands Healthcare Diagnostics & ResearchNetherlands Healthcare Netherlands Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $207.62 B |
| Danaher | $171.89 B |
| Siemens Healthineers AG | $66.05 B |
| DexCom, Inc. | $46.50 B |
| IDEXX Laboratories, Inc. | $44.72 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Koninklijke Philips N.V. has the following listings and related stock indices.
Stock: Euronext: PHIA wb_incandescent
Stock: BCBA: PHG wb_incandescent
Stock: BMV: PHIAN wb_incandescent
Stock: FSX: PHI1 wb_incandescent
Stock: MTA: PHIA wb_incandescent
Stock: XETR: PHI1 wb_incandescent
Stock: XETR: PHIA wb_incandescent
Stock: NYSE: PHG wb_incandescent
Stock: FSX: PHIA wb_incandescent
Product & Services
Medical equipmentHome appliancesIntellectual property management and licensing (for divested businesses of Philips, such as audiovisual equipment and lighting)
Key People
Founder(s): Gerard and Anton Philips
Jeroen van der Veer (Chairman) Frans van Houten (CEO) Abhijit Bhattacharya (CFO) Hugo Barbosa Vazquez (vice president)
Financials
Revenue: €19.535 billion (2020)
Operating income: €1.542 billion (2020)
Net income: €1.195 billion (2020)
Total assets: €27.713 billion (2020)
Total equity: €11.901 billion (2020)